Lipe & Dalton reduced its stake in AbbVie Inc. ( NYSE:ABBV – Get Rating ) by 1.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,509 shares of the company's stock after selling 773 shares during the quarter. AbbVie comprises approximately 3.9% of Lipe & Dalton's portfolio, making the stock its 2nd biggest holding. Lipe & Dalton's holdings in AbbVie were worth $6,708,000 as of its most recent filing with the Securities & Exchange Commission.

https://www.dailypolitical.com/2023/04/23/abbvie-inc-nyseabbv-is-lipe-daltons-2nd-largest-position.html

#dailypolitical